Augmedix Inc
Buy, Hold or Sell?

Let's analyse Augmedix together

Penke I guess you are interested in Augmedix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Augmedix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Augmedix Inc

I send you an email if I find something interesting about Augmedix Inc.

Quick analysis of Augmedix (30 sec.)

1. Valuation of Augmedix (5 min.)

Live pricePrice per share (EOD)

$4.07

Book Value per Share

$0.04

2. Growth of Augmedix (5 min.)

Is Augmedix growing?

	Current year	Previous year	Grow	Grow %
How rich?	$1.4m	$7.5m	-$2.3m	-46.0%

How much money is Augmedix making?

	Current year	Previous year	Grow	Grow %
Making money	-$6.4m	-$4.9m	-$1.4m	?
Net Profit Margin	-80.1%	-81.2%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Augmedix (5 min.)

4. Comparing to competitors in the Health Information Services industry (5 min.)

Industry Rankings (Health Information Services)

Richest
#124 / 161

Most Revenue
#92 / 161

Most Profit
#109 / 161

Most Efficient
#110 / 161

Fundamentals of Augmedix

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Augmedix Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Augmedix earns for each $1 of revenue.

Above 10% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
A Net Profit Margin of -65.8% means that $-0.66 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Augmedix Inc:

The MRQ is -65.8%. The company is making a huge loss. -2
The TTM is -80.1%. The company is making a huge loss. -2

Trends

Current period		Compared to		+/-
MRQ	-65.8%	TTM	-80.1%	+14.3%
TTM	-80.1%	YOY	-81.2%	+1.1%
TTM	-80.1%	5Y	-80.1%	0.0%
5Y	-80.1%	10Y	-80.1%	0.0%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-65.8%	-23.3%	-42.5%
TTM	-80.1%	-29.3%	-50.8%
YOY	-81.2%	-23.6%	-57.6%
5Y	-80.1%	-36.1%	-44.0%
10Y	-80.1%	-49.9%	-30.2%

Measures how much net profit Augmedix earns for each $1 of revenue.

Revenue is the amount of profit Augmedix generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Augmedix earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
Can be used to compare companies within the Health Information Services industry.

You typically want a high profit margin. This means that for each $1 in sales, Augmedix makes more profit. This shows the investor how efficiently Augmedix is operating in general and compared to other companies in the same industry. Augmedix operates in the Health Information Services industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Augmedix. If profit margins remain low (compared to the Health Information Services industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Augmedix is -0.66. This means that Augmedix earned $-0.66 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Health Information Services industry is -23.3%.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Augmedix with other companies in the same industry (Health Information Services).
Net profit margin should rise over the years.
Can be influenced when Augmedix sells assets (profit will increase while costs remain the same).
It won’t show what part of Augmedix is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Augmedix

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Augmedix = -5,758
Total revenue MRQ Augmedix = 8,751
$-5,758 / $8,751 = -0.66 or -65.8%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Augmedix is using its assets to generate profit.

Above 5% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
-17.1% Return on Assets means that Augmedix generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Augmedix Inc:

The MRQ is -17.1%. Using its assets, the company is very inefficient in making profit. -2
The TTM is -17.6%. Using its assets, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-17.1%	TTM	-17.6%	+0.5%
TTM	-17.6%	YOY	-15.2%	-2.4%
TTM	-17.6%	5Y	-47.4%	+29.8%
5Y	-47.4%	10Y	-47.4%	0.0%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-17.1%	-4.8%	-12.3%
TTM	-17.6%	-7.0%	-10.6%
YOY	-15.2%	-5.0%	-10.2%
5Y	-47.4%	-6.1%	-41.3%
10Y	-47.4%	-6.8%	-40.6%

Shows how efficient Augmedix is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Augmedix is using its resources to generate profit. If the return on assets (-17.1%) from Augmedix are higher than the Health Information Services mean (-4.8%) that means Augmedix is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Augmedix is -17.1%. This means the company generated $-0.17 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Health Information Services industry is -4.8%.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Augmedix

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Augmedix = -5,758
Total assets MRQ (balance sheet) from Augmedix = 33,641
-5,758 / 33,641 = -0.17 or -17.1%

ROA is an important ratio as it will tell you how effectively Augmedix is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Augmedix is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
-392.8% Return on Equity means Augmedix generated $-3.93 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Augmedix Inc:

The MRQ is -392.8%. Using its investors money, the company is very inefficient in making profit. -2
The TTM is -234.9%. Using its investors money, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-392.8%	TTM	-234.9%	-157.9%
TTM	-234.9%	YOY	-15.3%	-219.6%
TTM	-234.9%	5Y	-77.0%	-157.9%
5Y	-77.0%	10Y	-77.0%	0.0%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-392.8%	-4.6%	-388.2%
TTM	-234.9%	-8.2%	-226.7%
YOY	-15.3%	-6.3%	-9.0%
5Y	-77.0%	-8.6%	-68.4%
10Y	-77.0%	-9.6%	-67.4%

Shows how efficient Augmedix is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Health Information Services industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Augmedix is -392.8%. This means Augmedix generated $-3.93 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Health Information Services industry is -4.6%.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if Augmedix existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Augmedix

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Augmedix = -5,758
Shareholders equity (balance sheet) MRQ Augmedix = 1,466
-5,758 / 1,466 = -3.93 or -392.8%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Augmedix Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Augmedix is operating .

Measures how much profit Augmedix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
An Operating Margin of -64.2% means the company generated $-0.64 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Augmedix Inc:

The MRQ is -64.2%. The company is operating very inefficient. -2
The TTM is -54.0%. The company is operating very inefficient. -2

Trends

Current period		Compared to		+/-
MRQ	-64.2%	TTM	-54.0%	-10.1%
TTM	-54.0%	YOY	-67.4%	+13.4%
TTM	-54.0%	5Y	-64.5%	+10.4%
5Y	-64.5%	10Y	-64.5%	0.0%

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-64.2%	-28.5%	-35.7%
TTM	-54.0%	-24.2%	-29.8%
YOY	-67.4%	-18.1%	-49.3%
5Y	-64.5%	-23.0%	-41.5%
10Y	-64.5%	-32.9%	-31.6%

Measures how efficient Augmedix is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Augmedix to the Health Information Services industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Augmedix is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Augmedix is -64.2%. This means that Augmedix earned $-0.64 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Health Information Services industry is -28.5%.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Augmedix

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Augmedix = -5,440
Total revenue MRQ Augmedix = 8,751
$-5,440 / $8,751 = -0.64 or -64.2%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Augmedix is keeping operating costs low.

Below 1 is considered healthy (always compare to Health Information Services industry mean).
An Operation Ratio of 1.62 means that the operating costs are $1.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Augmedix Inc:

The MRQ is 1.622. The company is inefficient in keeping operating costs low. -1
The TTM is 1.825. The company is inefficient in keeping operating costs low. -1

Trends

Current period		Compared to		+/-
MRQ	1.622	TTM	1.825	-0.203
TTM	1.825	YOY	1.781	+0.044
TTM	1.825	5Y	1.729	+0.095
5Y	1.729	10Y	1.729	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	1.622	1.466	+0.156
TTM	1.825	1.504	+0.321
YOY	1.781	1.429	+0.352
5Y	1.729	1.403	+0.326
10Y	1.729	1.429	+0.300

Measures how efficient Augmedix is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Augmedix to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Augmedix is 162.2%. This means that Augmedix earned $1.62 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Health Information Services industry is 1.47.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Augmedix

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(4,702 +9,489) \ 8,751 = 1.62

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Augmedix Inc.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Augmedix is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
A Current Ratio of 3.21 means the company has $3.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Augmedix Inc:

The MRQ is 3.214. The company is very able to pay all its short-term debts. +2
The TTM is 3.825. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	3.214	TTM	3.825	-0.610
TTM	3.825	YOY	4.048	-0.224
TTM	3.825	5Y	2.842	+0.983
5Y	2.842	10Y	2.842	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	3.214	1.862	+1.352
TTM	3.825	1.900	+1.925
YOY	4.048	2.201	+1.847
5Y	2.842	2.222	+0.620
10Y	2.842	2.203	+0.639

Measures if Augmedix is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Augmedix if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Augmedix is 3.21. This means Augmedix has $3.21 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Health Information Services industry is 1.86.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Augmedix

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
28,342 \ 8,817) = 3.21

The current ratio measures if Augmedix is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Augmedix is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Augmedix does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Augmedix is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Augmedix is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Augmedix to the Health Information Services industry mean.
A Quick Ratio of 3.21 means the company can pay off $3.21 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Augmedix Inc:

The MRQ is 3.214. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 3.201. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	3.214	TTM	3.201	+0.013
TTM	3.201	YOY	3.969	-0.768
TTM	3.201	5Y	4.308	-1.107
5Y	4.308	10Y	4.308	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	3.214	1.137	+2.077
TTM	3.201	1.306	+1.895
YOY	3.969	1.577	+2.392
5Y	4.308	1.569	+2.739
10Y	4.308	1.548	+2.760

1.4. Solvency of Augmedix Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Augmedix assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Augmedix to Health Information Services industry mean.
A Debt to Asset Ratio of 0.96 means that Augmedix assets are financed with 95.6% credit (debt) and the remaining percentage (100% - 95.6%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Augmedix Inc:

The MRQ is 0.956. The company is just able to pay all its debts by selling its assets.
The TTM is 0.866. The company is just able to pay all its debts by selling its assets.

Trends

Current period		Compared to		+/-
MRQ	0.956	TTM	0.866	+0.090
TTM	0.866	YOY	0.932	-0.066
TTM	0.866	5Y	2.861	-1.995
5Y	2.861	10Y	2.861	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	0.956	0.433	+0.523
TTM	0.866	0.415	+0.451
YOY	0.932	0.386	+0.546
5Y	2.861	0.453	+2.408
10Y	2.861	0.470	+2.391

Measures how much % of Augmedix assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Augmedix than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Augmedix to Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Augmedix is 0.96. This means means that Augmedix is financed with 95.6% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Health Information Services industry is 186.2%.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Augmedix has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Augmedix

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
32,175 \ 33,641 = 95.6% or 0.96.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Augmedix is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Augmedix to the Health Information Services industry mean.
A Debt to Equity ratio of 2,194.7% means that company has $21.95 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Augmedix Inc:

The MRQ is 21.947. The company is unable to pay all its debts with equity. -1
The TTM is 12.821. The company is unable to pay all its debts with equity. -1

Trends

Current period		Compared to		+/-
MRQ	21.947	TTM	12.821	+9.126
TTM	12.821	YOY	0.682	+12.139
TTM	12.821	5Y	4.766	+8.056
5Y	4.766	10Y	4.766	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	21.947	0.629	+21.318
TTM	12.821	0.612	+12.209
YOY	0.682	0.580	+0.102
5Y	4.766	0.686	+4.080
10Y	4.766	0.664	+4.102

Measures if Augmedix is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Augmedix is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Augmedix is 21.95. This means that Augmedix can pay off $21.95 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is 0.63.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Augmedix

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
32,175 \ 1,466 = 21.95 or 2,194.7%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Augmedix Inc

2. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Augmedix generates.

Above 15 is considered overpriced but always compare Augmedix to the Health Information Services industry mean.
A PE ratio of -13.51 means the investor is paying $-13.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Augmedix Inc:

The EOD is -31.599. Company is losing money. -2
The MRQ is -13.509. Company is losing money. -2
The TTM is -11.354. Company is losing money. -2

Trends

Current period		Compared to		+/-
EOD	-31.599	MRQ	-13.509	-18.090
MRQ	-13.509	TTM	-11.354	-2.155
TTM	-11.354	YOY	-42.415	+31.061
TTM	-11.354	5Y	-19.734	+8.380
5Y	-19.734	10Y	-19.734	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	-31.599	-1.944	-29.655
MRQ	-13.509	-3.476	-10.033
TTM	-11.354	-5.504	-5.850
YOY	-42.415	-12.630	-29.785
5Y	-19.734	-10.049	-9.685
10Y	-19.734	-10.112	-9.622

Measures how much money you pay for each share for every $1 in earnings Augmedix generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Augmedix to the Health Information Services industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Augmedix is -13.51. This means the investor is paying $-13.51 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Health Information Services industry is -3.48.
What is the trend?
The trend is important because it shows you how Augmedix is performing over time. The most recent quarter might be important if Augmedix released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Augmedix up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Augmedix

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
-5,239 \ 37,432 = EPS
PE ratio MRQ = -13.51

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Augmedix.

Lower is better.
A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Augmedix Inc:

The MRQ is -12.693. Very Bad. -2
The TTM is -11.488. Very Bad. -2

Trends

Current period		Compared to		+/-
MRQ	-12.693	TTM	-11.488	-1.205
TTM	-11.488	YOY	-94.115	+82.627
TTM	-11.488	5Y	-53.461	+41.973
5Y	-53.461	10Y	-53.461	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
MRQ	-12.693	-0.057	-12.636
TTM	-11.488	-0.727	-10.761
YOY	-94.115	0.039	-94.154
5Y	-53.461	-0.144	-53.317
10Y	-53.461	10.151	-63.612

PEG Ratio	Meaning
0.5	You can buy the stock cheap based on future growth
1	You pay a fair price based on future growth
2	The stock is overpriced based on future growth

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Augmedix is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Health Information Services industry mean).
A PB ratio of 48.28 means the investor is paying $48.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Augmedix Inc:

The EOD is 112.926. Seems overpriced? -1
The MRQ is 48.278. Seems overpriced? -1
The TTM is 26.815. Seems overpriced? -1

Trends

Current period		Compared to		+/-
EOD	112.926	MRQ	48.278	+64.648
MRQ	48.278	TTM	26.815	+21.463
TTM	26.815	YOY	-17.133	+43.949
TTM	26.815	5Y	-12.766	+39.581
5Y	-12.766	10Y	-12.766	0.000

Compared to industry (Health Information Services)

Period	Company	Industry (mean)	+/-
EOD	112.926	1.626	+111.300
MRQ	48.278	2.214	+46.064
TTM	26.815	2.189	+24.626
YOY	-17.133	4.635	-21.768
5Y	-12.766	4.205	-16.971
10Y	-12.766	4.363	-17.129

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Augmedix Inc.

3.1. Institutions holding Augmedix Inc

Institutions are holding 76.737% of the shares of Augmedix Inc.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2022-12-31	Redmile Group, LLC	35.3538	0.9176	14380327	0	0
2023-03-31	Samjo Capital, LLC	4.4007	2.8256	1790000	90000	5.2941
2022-12-31	Perkins Capital Management Inc	4.1313	2.7669	1680428	1233528	276.0188
2023-03-31	Millrace Asset Group, Inc	2.1907	1.8088	891058	65840	7.9785
2022-12-31	Cowen Prime Advisors LLC	1.8244	0.4766	742100	742100	0
2023-03-31	Vanguard Group Inc	1.5479	0	629629	0	0
2023-03-31	American Financial Group Inc	1.2292	0.2702	500000	0	0
2022-12-31	TOWNSQUARE CAPITAL LLC	0.8711	0.0137	354331	-19406	-5.1924
2022-12-31	Geode Capital Management, LLC	0.5176	0.0001	210521	-419	-0.1986
2022-12-31	Blair William & Co	0.4893	0.0014	199038	-6525	-3.1742
2022-12-31	Boston Partners Global Investors, Inc	0.3109	0.0003	126466	28950	29.6874
2022-12-31	Spouting Rock Asset Management, LLC	0.1761	0.083	71625	0	0
2023-03-31	Northern Trust Corp	0.0996	0	40505	6861	20.3929
2023-03-31	BAKER TILLY FINANCIAL, LLC	0.096	0.0076	39066	-1043	-2.6004
2022-12-31	BlackRock Inc	0.0885	0	36005	768	2.1795
2023-03-31	DFPG Investments, Inc.	0.0718	0.0055	29186	518	1.8069
2022-12-31	Mariner Wealth Advisors, LLC	0.0662	0.0001	26944	15000	125.5861
2023-03-31	State Street Corporation	0.0583	0	23700	0	0
2023-03-31	FirstPurpose Wealth LLC	0.0351	0.0122	14275	2033	16.6068
2022-12-31	Envestnet Asset Management Inc	0.0284	0	11547	-1031	-8.1969
Total		53.5869	9.1896	21796751	+2157174	+9.9%

3.2. Funds holding Augmedix Inc

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-04-30	Vanguard Total Stock Mkt Idx Inv	1.0231	0.0001	416132	178413	75.0521
2023-04-30	Vanguard Extended Market Index Investor	0.9424	0.0014	383326	0	0
2023-03-31	Vanguard Instl Ttl Stck Mkt Idx Tr	0.5844	0	237719	0	0
2023-04-30	Russell Inv US Small Cap Equity E	0.5544	0.0764	225486	0	0
2023-03-31	WPG Partners Micro Cap Opportunities	0.5136	0.5675	208918	82452	65.197
2023-03-31	LoCorr Dynamic Opportunity I	0.4866	0.5858	197913	20063	11.2809
2023-02-28	WPG Partners Select Small Cap Value Ins	0.4483	0.3418	182357	4906	2.7647
2023-03-31	Fidelity® Extended Market Index	0.2477	0.0006	100738	0	0
2023-03-31	Russell Inv Multi-Asset Growth Strat S	0.2068	0.0213	84107	6955	9.0147
2023-04-30	Russell Inv Small Cap Fund B	0.2066	0.0553	84047	0	0
2023-03-31	Spouting Rock Small Cap Growth	0.1761	2.2491	71625	0	0
2023-04-30	Russell Inv US Small Cap Equity	0.1311	0.075	53331	-9799	-15.5219
2023-03-31	Fidelity® Series Total Market Index	0.1155	0.0002	46982	0	0
2023-03-31	Fidelity® Total Market Index	0.1155	0.0001	46963	0	0
2023-03-31	Russell Inv Multi-Strategy Income Y	0.0947	0.0162	38535	3186	9.013
2023-04-28	iShares Micro-Cap ETF	0.0819	0.0114	33296	0	0
2023-03-31	Russell Inv Gbl Smaller Companies Pl F	0.0516	0.0413	20982	0	0
2023-03-31	Northern Trust Extended Eq Market Idx	0.051	0.0007	20761	6861	49.3597
2023-03-31	NT Ext Equity Mkt Idx Fd - L	0.051	0.0007	20761	6861	49.3597
2023-04-30	Schwab Total Stock Market Index	0.0504	0.0004	20489	0	0
Total		6.1327	4.0453	2494468	+299898	+12.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Augmedix Inc compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	-	-0.103	0%	0.118	-100%	0.003	-100%	0.003	-100%
Book Value Growth	-	-	1.000	0.605	+65%	0.956	+5%	3.546	-72%	3.546	-72%
Book Value Per Share	-	-	0.036	0.126	-71%	0.184	-80%	0.099	-64%	0.099	-64%
Book Value Per Share Growth	-	-	1.000	0.605	+65%	0.956	+5%	3.546	-72%	3.546	-72%
Current Ratio	-	-	3.214	3.825	-16%	4.048	-21%	2.842	+13%	2.842	+13%
Debt To Asset Ratio	-	-	0.956	0.866	+10%	0.932	+3%	2.861	-67%	2.861	-67%
Debt To Equity Ratio	-	-	21.947	12.821	+71%	0.682	+3118%	4.766	+361%	4.766	+361%
Dividend Per Share	-	-	-	-	0%	-	0%	-	0%	-	0%
Eps	-	-	-0.129	-0.146	+13%	-0.116	-10%	-0.121	-6%	-0.121	-6%
Eps Growth	-	-	1.064	1.013	+5%	0.861	+24%	0.911	+17%	0.911	+17%
Free Cash Flow Per Share	-	-	-0.122	-0.110	-10%	-0.112	-9%	-0.127	+4%	-0.127	+4%
Free Cash Flow Per Share Growth	-	-	0.865	0.967	-11%	0.908	-5%	0.493	+76%	0.493	+76%
Free Cash Flow To Equity Per Share	-	-	-0.122	-0.118	-3%	0.110	-211%	-0.003	-97%	-0.003	-97%
Free Cash Flow To Equity Per Share Growth	-	-	0.865	0.938	-8%	2.133	-59%	1.758	-51%	1.758	-51%
Gross Profit Margin	-	-	1.406	1.275	+10%	1.453	-3%	1.312	+7%	1.312	+7%
Intrinsic Value_10Y_max	-	-	-2.228	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-4.788	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	-0.410	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	-0.503	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	-1.091	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	-1.500	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	-1.599	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-2.477	-	-	-	-	-	-	-	-
Net Profit Margin	-	-	-0.658	-0.801	+22%	-0.812	+23%	-0.801	+22%	-0.801	+22%
Operating Margin	-	-	-0.642	-0.540	-16%	-0.674	+5%	-0.645	+0%	-0.645	+0%
Operating Ratio	-	-	1.622	1.825	-11%	1.781	-9%	1.729	-6%	1.729	-6%
Pb Ratio	112.926	+57%	48.278	26.815	+80%	-17.133	+135%	-12.766	+126%	-12.766	+126%
Pe Ratio	-31.599	-134%	-13.509	-11.354	-16%	-42.415	+214%	-19.734	+46%	-19.734	+46%
Peg Ratio	-	-	-12.693	-11.488	-9%	-94.115	+641%	-53.461	+321%	-53.461	+321%
Price Per Share	4.070	+57%	1.740	1.638	+6%	4.298	-60%	2.211	-21%	2.211	-21%
Profit Growth	-	-	0.972	0.989	-2%	0.814	+19%	-25.046	+2678%	-25.046	+2678%
Quick Ratio	-	-	3.214	3.201	+0%	3.969	-19%	4.308	-25%	4.308	-25%
Return On Assets	-	-	-0.171	-0.176	+3%	-0.152	-11%	-0.474	+177%	-0.474	+177%
Return On Equity	-	-	-3.928	-2.349	-40%	-0.153	-96%	-0.770	-80%	-0.770	-80%
Revenue Growth	-	-	1.000	1.059	-6%	1.100	-9%	25.112	-96%	25.112	-96%
Total Gains Per Share	-	-	-	-0.103	0%	0.118	-100%	0.003	-100%	0.003	-100%
Total Gains Per Share Growth	-	-	2.000	1.249	+60%	4.174	-52%	5.096	-61%	5.096	-61%
Usd Book Value	-	-	1466000.000	5137500.000	-71%	7501000.000	-80%	4031057.308	-64%	4031057.308	-64%
Usd Book Value Change Per Share	-	-	-	-0.103	0%	0.118	-100%	0.003	-100%	0.003	-100%
Usd Book Value Per Share	-	-	0.036	0.126	-71%	0.184	-80%	0.099	-64%	0.099	-64%
Usd Dividend Per Share	-	-	-	-	0%	-	0%	-	0%	-	0%
Usd Eps	-	-	-0.129	-0.146	+13%	-0.116	-10%	-0.121	-6%	-0.121	-6%
Usd Free Cash Flow	-	-	-4978000.000	-4488750.000	-10%	-4542434.750	-9%	-5181066.769	+4%	-5181066.769	+4%
Usd Free Cash Flow Per Share	-	-	-0.122	-0.110	-10%	-0.112	-9%	-0.127	+4%	-0.127	+4%
Usd Free Cash Flow To Equity Per Share	-	-	-0.122	-0.118	-3%	0.110	-211%	-0.003	-97%	-0.003	-97%
Usd Price Per Share	4.070	+57%	1.740	1.638	+6%	4.298	-60%	2.211	-21%	2.211	-21%
Usd Profit	-	-	-5758000.000	-6430500.000	+12%	-4999500.000	-13%	-4488889.846	-22%	-4488889.846	-22%
Usd Revenue	-	-	8751000.000	8174750.000	+7%	6090000.000	+44%	5677388.769	+54%	5677388.769	+54%
Usd Total Gains Per Share	-	-	-	-0.103	0%	0.118	-100%	0.003	-100%	0.003	-100%
	EOD	+2 -2	MRQ	TTM	+16 -19	YOY	+9 -30	5Y	+15 -24	10Y	+15 -24

4.2. Fundamental Score

Let's check the fundamental score of Augmedix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	-31.599
Price to Book Ratio (EOD)	Between	0-1	112.926
Net Profit Margin (MRQ)	Greater than	0	-0.658
Operating Margin (MRQ)	Greater than	0	-0.642
Quick Ratio (MRQ)	Greater than	1	3.214
Current Ratio (MRQ)	Greater than	1	3.214
Debt to Asset Ratio (MRQ)	Less than	1	0.956
Debt to Equity Ratio (MRQ)	Less than	1	21.947
Return on Equity (MRQ)	Greater than	0.15	-3.928
Return on Assets (MRQ)	Greater than	0.05	-0.171
Total			3/10 (30.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Augmedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Open	Greater than	Close	4.110
Total			1/1 (100.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	33,641
Total Liabilities	32,175
Total Stockholder Equity	1,466

	As reported
Total Liabilities	32,175
Total Stockholder Equity	+ 1,466
Total Assets	= 33,641

Assets

Total Assets	33,641
Total Current Assets	28,342
Long-term Assets	28,342

Total Current Assets

Total Current Assets (as reported)	28,342
Cash And Cash Equivalents	21,988
Net Receivables	6,354
Total Current Assets (calculated)	28,342
+/-	0

Long-term Assets

Long-term Assets (as reported)	5,299
Property Plant Equipment	3,140
Long-term Assets Other	2,159
Long-term Assets (calculated)	5,299
+/-	0

Liabilities & Shareholders' Equity

Total Current Liabilities	8,817
Long-term Liabilities	23,358
Total Stockholder Equity	1,466

Total Current Liabilities

Total Current Liabilities (as reported)	8,817
Short-term Debt	4,622
Accounts payable	1,563
Other Current Liabilities	-4,622
Total Current Liabilities (calculated)	1,563
+/-	7,254

Long-term Liabilities

Long-term Liabilities (as reported)	23,358
Long term Debt Total	12,352
Long term Debt	12,352
Long-term Liabilities Other	509
Long-term Liabilities (calculated)	25,213
+/-	1,855

Total Stockholder Equity

Total Stockholder Equity (as reported)	1,466
Common Stock	4
Retained Earnings	-125,791
Accumulated Other Comprehensive Income	-440
Capital Surplus	127,693
Total Stockholder Equity (calculated)	1,466
+/-	0

Other

Cash and Short Term Investments	21,988
Common Stock Shares Outstanding	37,432
Common Stock Total Equity	4
Current Deferred Revenue	7,254
Liabilities and Stockholders Equity	33,641
Net Debt	-6,854
Net Invested Capital	20,233
Net Tangible Assets	1,466
Net Working Capital	17,909
Short Long Term Debt Total	15,134

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

> Total Assets

0
0
4
27,761
25,423
22,950
19,110
51,683
46,274
40,563
37,149
33,641
33,641

33,641

37,149

40,563

46,274

51,683

19,110

22,950

25,423

27,761

> Total Current Assets

8,958
8,958
4
26,769
24,092
21,710
17,654
48,765
41,193
35,475
32,050
28,342
28,342

28,342

32,050

35,475

41,193

48,765

17,654

21,710

24,092

26,769

8,958

Cash And Cash Equivalents

0
0
4
20,762
19,052
16,353
10,786
41,587
36,652
30,778
26,997
21,988
21,988

21,988

26,997

30,778

36,652

41,587

10,786

16,353

19,052

20,762

Net Receivables

2,992
2,992
2,562
2,693
3,880
3,775
5,542
7,178
4,209
4,697
5,053
6,354
6,354

6,354

5,053

4,697

4,209

7,178

5,542

3,775

3,880

2,693

2,562

2,992

Other Current Assets

2,000
2,000
2,000
3,314
1,159
1,582
1,326
1,993
1,805
1,729
1,656
1,820
1,945

1,945

1,820

1,656

1,729

1,805

1,993

1,326

1,582

1,159

3,314

2,000

> Long-term Assets

0
0
0
992
1,331
1,240
1,456
2,918
5,081
5,088
5,099
5,299
5,299

5,299

5,099

5,088

5,081

2,918

1,456

1,240

1,331

992

Property Plant Equipment

1,094
1,094
995
992
948
964
972
982
3,333
3,070
3,041
0
3,140

3,140

3,041

3,070

3,333

982

972

964

948

992

995

1,094

Long-term Assets Other

0
0
0
0
383
276
484
1,936
1,748
2,018
2,058
5,299
2,159

2,159

5,299

2,058

2,018

1,748

1,936

484

276

383

Deferred Long Term Asset Charges

0
0
0
0
0
0
208
0
0
0
0
0
0

208

> Total Liabilities

0
0
111
24,811
26,416
27,642
26,274
27,999
28,098
29,396
30,698
32,175
32,175

32,175

30,698

29,396

28,098

27,999

26,274

27,642

26,416

24,811

111

> Total Current Liabilities

13,464
13,464
111
16,473
9,788
10,679
11,294
7,603
6,662
7,447
7,805
8,817
8,817

8,817

7,805

7,447

6,662

7,603

11,294

10,679

9,788

16,473

111

13,464

Short-term Debt

0
0
0
6,613
6,613
0
0
0
3,853
860
2,741
0
4,622

4,622

2,741

860

3,853

6,613

Short Long Term Debt

0
0
0
6,613
0
0
0
1,500
3,000
0
1,875
3,750
0

3,750

1,875

3,000

1,500

6,613

Accounts payable

590
590
13
259
1,004
1,221
1,370
1,365
1,401
1,584
1,417
1,563
1,563

1,563

1,417

1,584

1,401

1,365

1,370

1,221

1,004

259

590

Other Current Liabilities

6,581
6,581
98
4,162
2,306
2,774
3,418
6,391
-3,853
-860
-2,741
0
-4,622

-4,622

-2,741

-860

-3,853

6,391

3,418

2,774

2,306

4,162

6,581

> Long-term Liabilities

0
0
0
8,338
16,629
16,963
14,980
20,396
21,436
21,949
22,893
23,358
23,358

23,358

22,893

21,949

21,436

20,396

14,980

16,963

16,629

8,338

Long term Debt Total

0
0
0
0
2,180
2,180
0
0
13,550
0
0
0
12,352

12,352

13,550

2,180

Deferred Long Term Asset Charges

0
0
0
0
0
0
208
0
0
0
0
0
0

208

Other Liabilities

0
0
0
0
64
254
296
5,559
496
7,017
7,860
0
0

7,860

7,017

496

5,559

296

254

Deferred Long Term Liability

0
0
935
0
64
254
296
0
0
0
0
0
0

296

254

935

> Total Stockholder Equity

0
0
-107
3,124
-994
-4,692
-7,164
23,684
18,176
11,167
6,451
1,466
1,466

1,466

6,451

11,167

18,176

23,684

-7,164

-4,692

-994

3,124

-107

Common Stock

0
0
1
3
3
3
3
4
4
4
4
0
4

Retained Earnings Total Equity

-125,791

-107,665

-96,278

-93,419

-88,782

Accumulated Other Comprehensive Income

-440

-327

-210

-79

-70

-46

-49

-52

Capital Surplus

0
0
0
0
87,834
88,773
89,157
0
125,916
0
0
0
127,693

127,693

125,916

89,157

88,773

87,834

Treasury Stock

Other Stockholders Equity

-53
-53
-108
3,173
87,834
88,773
89,157
125,479
125,916
126,485
126,966
0
127,693

127,693

126,966

126,485

125,916

125,479

89,157

88,773

87,834

3,173

-108

-53

Balance Sheet

Currency in USD. All numbers in thousands.

	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Accounts Payable	1,563	1,365	259	641	266
Accumulated Other Comprehensive Income	-440	-70	-52	-41	-
Capital Lease Obligations	1,840	-	-	-	-
Capital Stock	4	4	3	0	-
Capital Surpluse	127,693	-	87,051	-	-
Cash	21,988	41,587	20,762	9,603	-
Cash And Short Term Investments	21,988	41,587	20,762	9,603	-
Common Stock	4	4	3	0	0
Common Stock Shares Outstanding	37,418	28,915	26,864	26,864	-
Common Stock Total Equity	4	-	3	0	-
Current Deferred Revenue	7,254	6,238	6,492	6,563	-
Liabilities And Stockholders Equity	33,641	51,683	27,935	15,739	-
Long Term Debt	12,352	14,837	8,338	9,722	-
Long Term Debt Total	12,352	-	8,338	-	-
Net Debt	-6,854	-26,750	-5,811	3,012	-
Net Invested Capital	15,134	14,837	18,075	-52,526	-
Net Receivables	6,354	7,178	2,693	2,291	2,167
Net Tangible Assets	1,466	23,684	3,124	-65,141	-47,051
Net Working Capital	19,525	41,162	10,296	1,489	-
Non Current Assets Total	5,299	2,918	1,165	1,386	-
Non Current Liabilities Other	509	5,559	-	4,391	-
Non Current Liabilities Total	23,358	20,396	8,338	68,016	-
Non Currrent Assets Other	2,159	1,936	173	173	-
Other Assets	-	2,918	173	173	123
Other Current Assets	1,945	1,868	1,104	459	-
Other Current Liab	-4,622	-1,500	3,109	2,766	6,939
Other Liab	-	5,559	-	21	231
Other Stockholder Equity	127,693	125,479	87,051	3,174	-48
Property Plant And Equipment Gross	-	-	992	1,213	-
Property Plant And Equipment Net	3,140	982	992	1,213	-
Property Plant Equipment	1,573	982	992	1,213	1,348
Retained Earnings	-125,791	-101,729	-83,878	-68,274	-49,776
Retained Earnings Total Equity	-125,791	-	-83,878	-	-
Short Long Term Debt	3,750	1,500	6,613	2,894	-
Short Long Term Debt Total	15,134	14,837	14,951	12,615	-
Short Term Debt	4,622	1,500	6,613	2,894	-
Total Assets	33,641	51,683	27,935	15,739	-
Total Current Assets	28,342	48,765	26,770	14,353	12,533
Total Current Liabilities	8,817	7,603	16,473	12,864	9,083
Total Liab	32,175	27,999	24,811	80,880	-
Total Stockholder Equity	1,466	23,684	3,124	-65,141	-

	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Accounts Payable	1,563	1,563	1,417	1,584	1,401	1,365	1,370	1,221	1,004	259	13	590	590
Accumulated Other Comprehensive Income	-440	-	-327	-210	-79	-70	-46	-49	-49	-52	-	-	-
Capital Lease Obligations	-	1,840	2,034	2,226	2,415	-	-	-	-	-	-	-	-
Capital Stock	-	4	4	4	4	4	3	3	-	-	-	-	-
Capital Surpluse	127,693	-	-	-	125,916	-	89,157	88,773	87,834	-	-	-	-
Cash	21,988	21,988	26,997	30,778	36,652	41,587	10,786	16,353	19,052	20,762	4	-	-
Cash And Short Term Investments	21,988	-	26,997	30,778	36,652	41,587	10,786	16,353	19,052	20,762	4	-	-
Common Stock	4	-	4	4	4	4	3	3	3	3	1	0	0
Common Stock Shares Outstanding	37,432	37,443	37,432	37,424	37,411	37,158	27,124	27,020	26,861	26,864	26,864	26,864	26,864
Common Stock Total Equity	4	-	-	-	4	-	3	3	3	3	1	-	-
Current Deferred Revenue	7,254	-	6,388	5,863	5,261	6,238	6,455	6,632	6,427	5,439	-	-	-
Deferred Long Term Asset Charges	-	-	-	-	-	-	208	-	-	-	-	-	-
Deferred Long Term Liab	-	-	-	-	-	-	296	254	64	-	935	-	-
Liabilities And Stockholders Equity	33,641	-	37,149	40,563	46,274	51,683	19,110	22,950	25,423	27,935	4	-	-
Long Term Debt	12,352	15,134	15,033	14,932	14,988	14,837	14,684	2,180	2,180	8,338	-	-	-
Long Term Debt Total	12,352	-	-	-	13,550	-	-	2,180	2,180	-	-	-	-
Net Debt	-6,854	-	-11,964	-15,846	-21,664	-26,750	3,898	356	-2,487	-20,762	-4	-	-
Net Invested Capital	20,233	15,134	15,033	14,932	14,988	14,837	7,520	12,017	15,572	14,951	-	-	-
Net Receivables	6,354	6,354	5,053	4,697	4,209	7,178	5,542	3,775	3,880	2,693	2,562	2,992	2,992
Net Tangible Assets	1,466	-	6,451	11,167	18,176	23,684	-7,164	-4,692	-994	3,124	-76,470	-72,456	-65,141
Net Working Capital	17,909	19,525	24,245	28,028	34,531	41,162	6,360	11,031	14,304	10,297	-	-	-
Non Current Assets Total	5,299	5,299	5,099	5,088	5,081	2,918	1,456	1,240	1,331	992	-	-	-
Non Current Liabilities Other	509	8,224	7,860	7,017	6,448	5,559	14,684	14,529	14,385	-	-	-	-
Non Current Liabilities Total	23,358	23,358	22,893	21,949	21,436	20,396	14,980	16,963	16,629	8,338	-	-	-
Non Currrent Assets Other	2,159	5,299	2,058	2,018	1,748	1,936	484	276	383	-	-	-	-
Other Assets	-	-	5,099	5,088	275	2,918	484	276	383	173	1,108	173	173
Other Current Assets	1,945	1,820	1,656	1,729	1,805	1,993	1,326	1,582	1,159	3,314	2,000	2,000	2,000
Other Current Liab	-4,622	-	-2,741	-860	-3,853	6,391	3,418	2,774	2,306	4,162	98	6,581	6,581
Other Liab	-	-	7,860	7,017	496	5,559	296	254	64	-	-	-	-
Other Stockholder Equity	127,693	-	126,966	126,485	125,916	125,479	89,157	88,773	87,834	3,173	-108	-53	-53
Property Plant And Equipment Gross	-	-	-	-	-	-	-	964	948	992	-	-	-
Property Plant And Equipment Net	3,140	-	3,041	3,070	3,333	982	972	964	948	992	-	-	-
Property Plant Equipment	1,573	-	3,041	3,070	3,333	982	972	964	948	992	995	1,094	1,094
Retained Earnings	-125,791	-125,791	-120,192	-115,112	-107,665	-101,729	-96,278	-93,419	-88,782	-83,878	-80,088	-75,972	-75,972
Retained Earnings Total Equity	-125,791	-	-	-	-107,665	-	-96,278	-93,419	-88,782	-	-	-	-
Short Long Term Debt	-	3,750	1,875	-	3,000	1,500	-	-	-	6,613	-	-	-
Short Long Term Debt Total	15,134	-	15,033	14,932	14,988	14,837	14,684	16,709	16,565	-	-	-	-
Short Term Debt	4,622	-	2,741	860	3,853	-	-	-	6,613	6,613	-	-	-
Total Assets	33,641	33,641	37,149	40,563	46,274	51,683	19,110	22,950	25,423	27,761	4	-	-
Total Current Assets	28,342	28,342	32,050	35,475	41,193	48,765	17,654	21,710	24,092	26,769	4	8,958	8,958
Total Current Liabilities	8,817	8,817	7,805	7,447	6,662	7,603	11,294	10,679	9,788	16,473	111	13,464	13,464
Total Liab	32,175	32,175	30,698	29,396	28,098	27,999	26,274	27,642	26,416	24,811	111	-	-
Total Stockholder Equity	1,466	1,466	6,451	11,167	18,176	23,684	-7,164	-4,692	-994	3,124	-107	-	-

Cash Flow

Currency in USD. All numbers in thousands.

	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Begin Period Cash Flow	41,587	22,973	11,603	9,914	-
Capital Expenditures	1,408	611	647	823	342
Cash And Cash Equivalents Changes	-19,418	-	11,371	-	-
Cash Flows Other Operating	984	-	-857	-	-
Change In Cash	-19,599	18,614	11,370	1,689	1,914
Change In Working Capital	874	-1,998	-1,020	1,234	-
Change Receivables	786	-	-402	-	-
Change To Account Receivables	786	-4,431	-402	-126	-661
Change To Liabilities	2,201	1,814	29	1,019	2,079
Change To Netincome	2,849	-741	1,568	1,670	721
Change To Operating Activities	-	619	-149	342	541
Depreciation	856	691	867	949	1,588
Dividends Paid	-	-	0	0	-
End Period Cash Flow	21,988	41,587	22,973	11,603	9,914
Free Cash Flow	-18,181	-19,203	-15,046	-15,468	-
Investments	-1,408	-611	-647	-823	-
Issuance Of Capital Stock	0	40,000	27,917	15,271	-
Net Borrowings	14,858	2,034	-979	1,946	1,324
Net Income	-24,449	-17,851	-15,604	-18,498	-24,163
Other Cashflows From Financing Activities	14,858	10,793	-1,000	18,526	-53
Other Cashflows From Investing Activities	-	-611	-611	-611	-611
Other Non Cash Items	3,834	-821	690	1,273	-
Sale Purchase Of Stock	30	-	27,997	-	-
Stock Based Compensation	2,112	1,387	668	397	-
Total Cash From Financing Activities	-1,237	37,827	26,417	17,168	22,150
Total Cash From Operating Activities	-16,773	-18,592	-14,399	-14,645	-19,895
Total Cashflows From Investing Activities	-1,408	-611	-647	-823	-342

	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Begin Period Cash Flow	26,997	26,997	30,778	36,984	41,587	11,118	16,685	19,337	22,973	4	5,411	6,223	11,603
Capital Expenditures	592	592	201	162	453	188	105	161	157	647	112	58	257
Cash And Cash Equivalents Changes	-1,309	-	-	-	-4,599	-	-5,565	-2,651	-3,636	-	-	-	-
Cash Flows Other Operating	-450	-	-	-	19	-	377	522	62	-	-	-	-
Change In Cash	-5,009	-5,009	-3,781	-6,206	-4,603	30,469	-5,567	-2,652	-3,636	22,969	-1,982	-812	-5,380
Change In Working Capital	-3,458	4	880	627	701	-889	-1,223	1,346	-1,232	-542	1,447	-351	-1,574
Change Receivables	58	-	-	-	2,956	-	-1,767	106	-1,188	-	-	-	-
Change To Account Receivables	-1,323	-1,323	-359	-488	2,956	-1,582	-1,767	106	-1,188	-402	342	-248	-365
Change To Liabilities	-1,494	-	137	940	-940	603	289	908	-63	237	34	-370	-333
Change To Netincome	625	-	-14,865	-9,593	737	169	-1,653	382	592	11	709	319	304
Change To Operating Activities	-	-	1,003	1,315	-1,315	90	414	878	-763	-647	1,071	-287	-876
Depreciation	249	249	-114	382	339	168	156	165	202	867	214	214	218
Dividends Paid	-	-	-	-	-	-	-	0	0	0	-	0	-
End Period Cash Flow	21,988	21,988	26,997	30,778	36,984	41,587	11,118	16,685	19,337	22,973	3,429	5,411	6,223
Free Cash Flow	-4,978	-4,386	-3,732	-4,859	-4,612	-5,282	-5,562	-2,714	-5,457	-15,046	-1,859	-2,992	-5,875
Investments	-173	-592	-201	-162	-453	-188	-105	-161	-157	-220	-112	-58	-257
Net Borrowings	5,000	-	1,125	-1,125	-1,125	-1,125	-1,125	-37	1,839	2,034	2,034	1,090	1,090
Net Income	-5,599	-5,599	-5,467	-7,447	-5,936	-5,451	-2,859	-4,637	-4,904	-16	-18	-2,959	-4,738
Other Cashflows From Financing Activities	-23	-	4	14,864	13	-137,806	-3	63	14,787	-1,000	-125	2,180	498
Other Cashflows From Investing Activities	-	-	-816	-615	-615	-188	-188	-188	-188	-	-	-	-
Other Non Cash Items	3,702	212	693	1,250	313	1,058	-1,902	334	250	-15,377	-3,489	-132	379
Sale Purchase Of Stock	85	-	-	-	13	-	-3	100	4	-	-	-	-
Stock Based Compensation	720	720	477	491	424	393	371	239	384	668	99	295	97
Total Cash From Financing Activities	7	7	4	-1,261	13	35,946	-3	62	1,822	26,417	-125	2,180	498
Total Cash From Operating Activities	-4,386	-4,386	-3,531	-4,697	-4,159	-5,282	-5,457	-2,553	-5,300	-14,399	-1,747	-2,934	-5,618
Total Cashflows From Investing Activities	-173	-	-201	-162	-453	-188	-105	-161	-157	-220	-112	-158	-257

Income Statement

Currency in USD. All numbers in thousands.

	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Cost Of Revenue	16,979	12,158	9,689	9,428	-
Depreciation And Amortization	-	87	867	2,006	-
Ebit	-22,663	-17,938	-14	-16,743	-22,922
Ebitda	-22,371	-17,938	-13,693	-14,737	-
Gross Profit	13,954	10,007	6,794	4,679	-
Income Before Tax	-24,449	-17,851	-15,604	-18,498	-
Income Tax Expense	2,078	-3,189	-409	1,756	-
Interest Expense	2,078	2,498	1,453	2,812	0
Interest Income	245	15	11	6	-
Net Income	-26,527	-14,662	-15,195	-20,254	-
Net Income Applicable To Common Shares	-24,449	-17,851	-15,604	-18,498	-24,163
Net Income From Continuing Ops	-24,449	-17,851	-15,604	-18,498	-
Net Interest Income	-1,430	-2,483	-1,442	-2,806	-
Non Operating Income Net Other	-292	-	-458	-	-
Operating Income	-22,371	-17,938	-13,693	-16,743	-
Other Operating Expenses	53,304	40,103	30,176	30,850	-
Reconciled Depreciation	856	691	867	949	-
Research Development	10,149	6,678	4,522	6,977	-
Selling And Marketing Expenses	9,283	7,508	4,398	3,583	-
Selling General Administrative	16,893	13,759	11,567	10,861	-
Tax Provision	111	-	-	-	-
Total Operating Expenses	36,325	27,945	20,487	21,422	-
Total Other Income Expense Net	-2,078	87	-1,911	-1,756	-
Total Revenue	30,933	22,165	16,483	14,108	-

	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Cost Of Revenue	4,702	4,702	4,274	4,131	3,872	3,640	3,092	2,761	2,665	10	2,369	2,195	2,590
Depreciation And Amortization	520	-	170	-629	449	-624	156	165	202	867	214	214	218
Ebit	-5,614	-	-5,458	-6,051	-5,445	-4,827	-2,270	-4,032	-4,213	-14	-20	-2,520	-4,382
Ebitda	-5,440	-5,440	-5,458	-6,051	-5,445	-5,451	-2,114	-3,867	-4,011	853	194	-2,306	-4,164
Gross Profit	4,049	4,049	3,590	3,202	3,113	2,937	2,533	2,412	2,125	7	1,877	1,530	1,380
Income Before Tax	-5,599	-5,599	-5,490	-7,447	-5,936	-5,451	-2,859	-4,637	-4,904	-16	-18	-2,959	-4,738
Income Tax Expense	159	-	32	1,396	491	624	-	-	-	-	-	-	-
Interest Expense	159	373	316	385	601	624	589	605	692	1	1	439	357
Interest Income	-	177	59	4	5	7	1	3	4	8	0	3	0
Net Income	-5,758	-5,599	-5,522	-8,843	-6,427	-6,075	-2,859	-4,637	-4,904	-16	-18	-2,959	-4,738
Net Income Applicable To Common Shares	-5,239	-	-5,490	-7,447	-5,936	-5,451	-2,859	-4,637	-4,904	-3,790	-4,116	-3,849	-4,738
Net Income From Continuing Ops	-5,239	-5,599	-5,490	-7,447	-5,936	-5,451	-2,859	-4,637	-4,904	-3,790	-4,116	-2,959	-4,738
Net Interest Income	-	-196	-257	-381	-596	-606	-588	-602	-688	-248	-402	-436	-356
Non Operating Income Net Other	296	-	-	-	110	-	2,402	3	191	-	-	-	-
Operating Income	-5,440	-5,440	-5,458	-6,051	-5,445	-4,827	-4,672	-4,035	-4,404	-3,569	-3,355	-2,550	-4,218
Other Operating Expenses	14,191	-	13,322	13,384	12,430	11,404	10,297	9,208	9,194	30	17	6,275	8,188
Reconciled Depreciation	-	249	-114	382	339	168	156	165	202	222	214	214	218
Research Development	2,612	2,612	2,608	2,649	2,280	1,943	1,810	1,499	1,426	5	1,009	985	1,491
Selling And Marketing Expenses	2,339	-	2,304	2,432	2,231	2,049	2,157	1,728	1,574	4	-	819	1,239
Selling General Administrative	4,538	6,877	4,136	4,172	4,047	9,973	3,238	3,220	3,529	12	17	2,276	2,868
Total Operating Expenses	9,489	14,191	9,048	9,253	8,558	7,764	7,205	6,447	6,529	20	17	4,080	5,598
Total Other Income Expense Net	-159	-159	-32	-1,396	-491	-624	1,813	-602	-500	3,554	3,337	-409	-520
Total Revenue	8,751	8,751	7,864	7,333	6,985	6,577	5,625	5,173	4,790	16	4,245	3,725	3,970

Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue	30,933
Cost of Revenue	-16,979
Gross Profit	13,954	13,954

Operating Income (+$)
Gross Profit	13,954
Operating Expense	-36,325
Operating Income	-22,371	-22,371

Operating Expense (+$)
Research Development	10,149
Selling General Administrative	16,893
Selling And Marketing Expenses	9,283
Operating Expense	36,325	36,325

Net Interest Income (+$)
Interest Income	245
Interest Expense	-2,078
Other Finance Cost	-403
Net Interest Income	-1,430

Pretax Income (+$)
Operating Income	-22,371
Net Interest Income	-1,430
Other Non-Operating Income Expenses	-292
Income Before Tax (EBT)	-24,449	-20,293 EBIT - interestExpense = -24,741 -24,449 -24,449
Interest Expense	2,078
Earnings Before Interest and Taxes (EBIT)	-22,663	-22,371
Earnings Before Interest and Taxes (EBITDA)	-22,371

After tax Income (+$)
Income Before Tax	-24,449
Tax Provision	-111
Net Income From Continuing Ops	-24,449	-24,560
Net Income	-26,527
Net Income Applicable To Common Shares	-24,449

Non-recurring Events
Discontinued Operations	-
Extraordinary Items	-
Effect of Accounting Charges	-
Other Items	-
Non Recurring	-
Other Operating Expenses	53,304
Total Other Income/Expenses Net	-2,078	1,722

Technicals of Augmedix

1. Trend Indicators

1.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Directionalities and relatives.

Moving Average	Amount of candles	Trend	Price +/-	vs. MA 50	vs. MA 100	vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Augmedix Inc Daily Moving Averages Chart

1.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Let's take a look of the Moving Average Convergence/Divergence (MACD) of Augmedix Inc:

Augmedix Inc Daily Moving Average Convergence/Divergence (MACD) Chart

1.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index).

The ADX helps you determine the strength of a trend. Let's take a look of the ADX of Augmedix Inc:

The ADX is .

Augmedix Inc Daily Directional Movement Index (DMI) Chart

1.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

The Parabolic SAR is lower than the price. The current trend is up. +2

2. Momentum Indicators

2.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

The RSI is below 50. -1
The RSI is below 30 and oversold. +2

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Augmedix Inc Daily Relative Strength Index (RSI) Chart

2.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

The Stochastic is below 50. -1
The Stochastic is below 30 and oversold. +2

Augmedix Inc Daily Stochastic Oscillator Chart

2.3 Commodity Channel Index (CCI)

Augmedix Inc Daily Commodity Channel Index (CCI) Chart

2.4 Chande Momentum Oscillator (CMO)

Augmedix Inc Daily Chande Momentum Oscillator (CMO) Chart

2.5 Williams %R

3. Volatility Indicators

3.1 Bollinger Bands

Augmedix Inc Daily Bollinger Bands Chart

3.2 Average True Range (ATR)

Augmedix Inc Daily Average True Range (ATR) Chart

4. Volume Indicators

4.1 On-Balance Volume (OBV)

Augmedix Inc Daily On-Balance Volume (OBV) Chart

4.2 Money Flow Index (MFI)

Augmedix Inc Daily Money Flow Index (MFI) Chart

5. Summary

5.1. Notifications

Type	Notification	Date
Currently no notifications for Augmedix Inc.

5.2. Trading Signals

Date	Indicator	Entry signal	Exit signal
2023-06-01	STOCH	SHORT ENTRY	LONG CLOSE	80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE
2023-06-02	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside

5.2. Technical Score

Let's check the technical score of Augmedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Open	Greater than	Close	4.110
Total			1/1 (100.0%)

Create your own Symbol Scanner

Comments

Join the conversation.

Augmedix Inc Buy, Hold or Sell?

Let's analyse Augmedix together

Get notifications about Augmedix Inc

Quick analysis of Augmedix (30 sec.)

1. Valuation of Augmedix (5 min.)

$4.07

$0.04

2. Growth of Augmedix (5 min.)

Is Augmedix growing?

How much money is Augmedix making?

How much money comes from the company's main activities?

3. Financial Health of Augmedix (5 min.)

4. Comparing to competitors in the Health Information Services industry (5 min.)

Industry Rankings (Health Information Services)

Fundamentals of Augmedix

Financial Health

1.1. Profitability of Augmedix Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Health Information Services)

1.1.2. Return on Assets

Trends

Compared to industry (Health Information Services)

1.1.3. Return on Equity

Trends

Compared to industry (Health Information Services)

1.2. Operating Efficiency of Augmedix Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Health Information Services)

1.2.2. Operating Ratio

Trends

Compared to industry (Health Information Services)

1.3. Liquidity of Augmedix Inc.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Health Information Services)

1.3.2. Quick Ratio

Trends

Compared to industry (Health Information Services)

1.4. Solvency of Augmedix Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Health Information Services)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Health Information Services)

2. Market Valuation of Augmedix Inc

2. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Health Information Services)

2.2. Price Earnings to Growth Ratio

Trends

Compared to industry (Health Information Services)

2. Book Value per Share

2.3. Price to Book Ratio

Trends

Compared to industry (Health Information Services)

Augmedix Inc
Buy, Hold or Sell?